Invitae's Series C Round

Invitae raised a round of funding on February 06, 2012. Investors include Genomic Health.

Invitae (NYSE: NVTA), fka Locus Development, is a genetic information company that aims to bring genetic information into mainstream medical practice to improve the quality of healthcare. The company …

Articles about Invitae's Series C Round: